Harnessing Placebo Effects: Non-Deceptive Use of Placebo in Irritable Bowel Syndrome (IBS)

Completed · Not applicable

Conditions studied: Irritable Bowel Syndrome

In brief

Irritable bowel syndrome patients will be given either placebo pill or no treatment for a period of 3 weeks.

Key facts

Study ID

NCT01010191

Run by

Harvard University Faculty of Medicine

People needed

70

Starts

2008-07-01

Expected to finish

2010-04-01

Last updated by the study team

2011-06-22

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Irritable bowel syndrome.

You may not qualify if…

• Any signs of organic bowel disease such as rectal bleeding.
• No other major illnesses.

Where it is running

• Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.